Amgen — Drug Prices & Medicare Spending

Amgen manufactures 11 drugs tracked by Medicare Part D with total spending of $10.8B.

Drugs Tracked

$10.8B

Medicare Spending

$852.89

Avg Cost/Claim

82%

Have Generics

Amgen Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Repatha	Evolocumab	$757.00	$2.6B	+24.6%	No
2	Otezla	Apremilast	$1,873.00	$2.1B	-2.1%	Yes
3	Enbrel	Etanercept	$1,726.00	$1.7B	-15.2%	No
4	Prolia	Denosumab	$632.00	$1.6B	+6.4%	Yes
5	Kyprolis	Carfilzomib	$11,204.00	$1.1B	+2.3%	Yes
6	Aranesp	Darbepoetin Alfa	$457.00	$567.0M	-4.8%	Yes
7	Epogen	Epoetin Alfa	$399.00	$345.0M	-12.6%	Yes
8	Lumakras	Sotorasib	$13,000.00	$234.0M	+28.4%	Yes
9	Corlanor	Ivabradine	$375.00	$234.0M	+4.6%	Yes
10	Parsabiv	Etelcalcetide	$375.00	$234.0M	+6.2%	Yes
11	Cinacalcet	Cinacalcet	$144.00	$178.0M	-18.6%	Yes

Amgen manufactures 11 drugs tracked by Medicare Part D, with total annual spending of $10.8B.

Lumakras (Sotorasib) is the most expensive at $13,000.00 per claim.

9 of 11 Amgen drugs (82%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.